
Sara K. Tedeschi, MD, MPH, is a rheumatologist and clinical investigator focused on crystalline arthritis. She is Assistant Professor of Medicine at Harvard Medical School and Associate Physician in the Division of Rheumatology, Inflammation, and Immunity at Brigham and Women’s Hospital, where she serves as Head of Crystalline Arthritic Diseases and served as Director of the Giant Cell Arteritis Fast Track Clinic (2019-2026). Her clinical practice focuses on calcium pyrophosphate deposition (CPPD) disease, gout, and giant cell arteritis. She is Principal Investigator of an NIH-funded multi-site randomized controlled trial of colchicine vs. placebo in CPPD disease (NCT06855433). Her leadership roles include Co-Chair of the OMERACT CPPD Working Group, leadership team member for the ACR/EULAR CPPD Disease Classification Criteria Committee, committee member of the ACR Committee on Quality of Care, and former member of the Lupus Foundation of America’s Medical-Scientific Advisory Council. Among her honors are the American College of Rheumatology Distinguished Fellow Award and election to Alpha Omega Alpha. She earned her MD from Vanderbilt University School of Medicine, completed her Internal Medicine residency and Rheumatology fellowship at Brigham and Women’s Hospital, and received her MPH from the Harvard T.H. Chan School of Public Health.
Assistant Professor
Medical School
2006 – 2010
Residency
2010 – 2013
Fellowship
2013 – 2016